Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Shprecher

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2019
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesiaHubert H Fernandez, David Stamler, Mat D Davis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 10, 2024
Conjugal Synucleinopathies: A Clinicopathologic StudyCharles H Adler, Matthew Halverson, Nan Zhang, et al.
Neurology|April 28, 2017
Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD studyHubert H Fernandez, Stewart A Factor, Robert A Hauser, et al.
Parkinsonism & Related Disorders|May 22, 2018
Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosisDavid R Shprecher, Charles H Adler, Nan Zhang, et al.
Acta Neurologica Scandinavica|September 20, 2018
Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyRodolfo Savica, Thomas G Beach, Joseph G Hentz, et al.
Journal of Parkinson'S Disease|January 6, 2026
Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's diseaseDelaram Safarpour, Annie Brooks, Adrianne Smiley, et al.
Journal of Neuropathology and Experimental Neurology|June 1, 2026
Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assaysChelva Janarthanam, Christina D Orrú, Andrew G Hughson, et al.
Plos One|April 23, 2020
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementiaThomas G Beach, Charles H Adler, Nan Zhang, et al.
Annals of Clinical and Translational Neurology|February 8, 2023
Baseline characteristics of the North American prodromal Synucleinopathy cohortJonathan E Elliott, Miranda M Lim, Allison T Keil, et al.
Molecular Neurodegeneration|September 25, 2015
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's diseaseIgnacio F Mata, Yongwoo Jang, Chun-Hyung Kim, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2019
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesiaHubert H Fernandez, David Stamler, Mat D Davis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 10, 2024
Conjugal Synucleinopathies: A Clinicopathologic StudyCharles H Adler, Matthew Halverson, Nan Zhang, et al.
Neurology|April 28, 2017
Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD studyHubert H Fernandez, Stewart A Factor, Robert A Hauser, et al.
Parkinsonism & Related Disorders|May 22, 2018
Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosisDavid R Shprecher, Charles H Adler, Nan Zhang, et al.
Acta Neurologica Scandinavica|September 20, 2018
Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyRodolfo Savica, Thomas G Beach, Joseph G Hentz, et al.
Journal of Parkinson'S Disease|January 6, 2026
Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's diseaseDelaram Safarpour, Annie Brooks, Adrianne Smiley, et al.
Journal of Neuropathology and Experimental Neurology|June 1, 2026
Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assaysChelva Janarthanam, Christina D Orrú, Andrew G Hughson, et al.
Plos One|April 23, 2020
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementiaThomas G Beach, Charles H Adler, Nan Zhang, et al.
Annals of Clinical and Translational Neurology|February 8, 2023
Baseline characteristics of the North American prodromal Synucleinopathy cohortJonathan E Elliott, Miranda M Lim, Allison T Keil, et al.
Molecular Neurodegeneration|September 25, 2015
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's diseaseIgnacio F Mata, Yongwoo Jang, Chun-Hyung Kim, et al.
Pageof 4